Disruptive Behavior clinical trials at UC Health

• Prazosin for Agitation in Alzheimer's Disease

  Sorry, in progress, not accepting new patients

  The study evaluates the effects of Prazosin on agitation in adults with Alzheimer's disease. Two thirds of the participants will participate in the medication portion, while one third will participate in the placebo portion

  at UCLA UCSD

Last updated: March 18, 2020